Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Colorectal Neoplasms

Free Subscription Articles published in Gut Retrieve available abstracts of 93 articles: HTML format

Single Articles

March 2020
1. TJALMA JJJ, Koller M, Linssen MD, Hartmans E, et al
   Quantitative fluorescence endoscopy: an innovative endoscopy approach to evaluate neoadjuvant treatment response in locally advanced rectal cancer.
   Gut. 2020;69:406-410.
   PubMed    
   
   
   
2. SENORE C, Zappa M, Campari C, Crotta S, et al
   Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy.
   Gut. 2020;69:523-530.
   PubMed     Abstract available
   
   
   February 2020
3. WAN QY, Zhao R, Wang Y, Wu Y, et al
   Antibiotic use and risk of colorectal cancer: a meta-analysis of 412 450 participants.
   Gut. 2020 Feb 28. pii: gutjnl-2020-320826. doi: 10.1136/gutjnl-2020-320826.
   PubMed    
   
   
   
4. YEOH YK, Chen Z, Wong MCS, Hui M, et al
   Southern Chinese populations harbour non-nucleatum Fusobacteria possessing homologues of the colorectal cancer-associated FadA virulence factor.
   Gut. 2020 Feb 12. pii: gutjnl-2019-319635. doi: 10.1136/gutjnl-2019-319635.
   PubMed     Abstract available
   
   
   
5. NG SC, Kyaw MH, Suen BY, Tse YK, et al
   Prospective colonoscopic study to investigate risk of colorectal neoplasms in first-degree relatives of patients with non-advanced adenomas.
   Gut. 2020;69:304-310.
   PubMed     Abstract available
   
   
   January 2020
6. PICHLER M, Rodriguez-Aguayo C, Nam SY, Dragomir MP, et al
   Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.
   Gut. 2020 Jan 27. pii: gutjnl-2019-318903. doi: 10.1136/gutjnl-2019-318903.
   PubMed     Abstract available
   
   
   
7. CROSS AJ, Robbins EC, Pack K, Stenson I, et al
   Long-term colorectal cancer incidence after adenoma removal and the effects of surveillance on incidence: a multicentre, retrospective, cohort study.
   Gut. 2020 Jan 17. pii: gutjnl-2019-320036. doi: 10.1136/gutjnl-2019-320036.
   PubMed     Abstract available
   
   
   
8. BLEIJENBERG AG, IJspeert JE, van Herwaarden YJ, Carballal S, et al
   Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort study.
   Gut. 2020;69:112-121.
   PubMed     Abstract available
   
   
   December 2019
9. MA W, Chan AT
   Antibiotic use and colorectal cancer: a causal association?
   Gut. 2019 Dec 24. pii: gutjnl-2019-319792. doi: 10.1136/gutjnl-2019-319792.
   PubMed    
   
   
   
10. ZORZI M, Cavestro GM, Guzzinati S, Dal Maso L, et al
    Decline in the incidence of colorectal cancer and the associated mortality in young Italian adults.
    Gut. 2019 Dec 16. pii: gutjnl-2019-320406. doi: 10.1136/gutjnl-2019-320406.
    PubMed    
    
    
    
11. MATHEW A, Baby B, Wang K, Sirohi B, et al
    Colorectal cancer incidence in younger adults in India.
    Gut. 2019 Dec 13. pii: gutjnl-2019-320271. doi: 10.1136/gutjnl-2019-320271.
    PubMed    
    
    
    
12. MONTAZERI Z, Li X, Nyiraneza C, Ma X, et al
    Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer.
    Gut. 2019 Dec 9. pii: gutjnl-2019-319313. doi: 10.1136/gutjnl-2019-319313.
    PubMed     Abstract available
    
    
    
13. DE BARRIOS O, Sanchez-Moral L, Cortes M, Ninfali C, et al
    ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells.
    Gut. 2019;68:2129-2141.
    PubMed     Abstract available
    
    
    November 2019
14. REICHLING C, Taieb J, Derangere V, Klopfenstein Q, et al
    Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study.
    Gut. 2019 Nov 28. pii: gutjnl-2019-319292. doi: 10.1136/gutjnl-2019-319292.
    PubMed     Abstract available
    
    
    
15. MONAHAN KJ, Bradshaw N, Dolwani S, Desouza B, et al
    Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).
    Gut. 2019 Nov 28. pii: gutjnl-2019-319915. doi: 10.1136/gutjnl-2019-319915.
    PubMed     Abstract available
    
    
    
16. RUTTER MD, East J, Rees CJ, Cripps N, et al
    British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines.
    Gut. 2019 Nov 27. pii: gutjnl-2019-319858. doi: 10.1136/gutjnl-2019-319858.
    PubMed     Abstract available
    
    
    October 2019
17. KUIPERS EJ, Grobbee EJ
    Personalised screening for colorectal cancer, ready for take-off.
    Gut. 2019 Oct 15. pii: gutjnl-2019-319677. doi: 10.1136/gutjnl-2019-319677.
    PubMed    
    
    
    
18. WANG P, Berzin TM, Glissen Brown JR, Bharadwaj S, et al
    Real-time automatic detection system increases colonoscopic polyp and adenoma detection rates: a prospective randomised controlled study.
    Gut. 2019;68:1813-1819.
    PubMed     Abstract available
    
    
    September 2019
19. KLEEMAN SO, Koelzer VH, Jones HJ, Vazquez EG, et al
    Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification.
    Gut. 2019 Sep 28. pii: gutjnl-2019-319126. doi: 10.1136/gutjnl-2019-319126.
    PubMed     Abstract available
    
    
    
20. SIEGEL RL, Torre LA, Soerjomataram I, Hayes RB, et al
    Global patterns and trends in colorectal cancer incidence in young adults.
    Gut. 2019 Sep 5. pii: gutjnl-2019-319511. doi: 10.1136/gutjnl-2019-319511.
    PubMed     Abstract available
    
    
    
21. SCOTT AJ, Alexander JL, Merrifield CA, Cunningham D, et al
    International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis.
    Gut. 2019;68:1624-1632.
    PubMed     Abstract available
    
    
    
22. KANDEL P, Brand EC, Pelt J, Ball CT, et al
    Endoscopic scar assessment after colorectal endoscopic mucosal resection scars: when is biopsy necessary (EMR Scar Assessment Project for Endoscope (ESCAPE) trial).
    Gut. 2019;68:1633-1641.
    PubMed     Abstract available
    
    
    
23. CROSS AJ, Wooldrage K, Robbins EC, Kralj-Hans I, et al
    Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study.
    Gut. 2019;68:1642-1652.
    PubMed     Abstract available
    
    
    August 2019
24. ZHANG J, Haines C, Watson AJM, Hart AR, et al
    Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012: a matched case-control study.
    Gut. 2019 Aug 19. pii: gutjnl-2019-318593. doi: 10.1136/gutjnl-2019-318593.
    PubMed     Abstract available
    
    
    July 2019
25. WEI T, Luo P, Zhang X, Zhu W, et al
    Comparison of the incidence of colorectal cancer in young adults between the USA and Europe.
    Gut. 2019 Jul 31. pii: gutjnl-2019-319391. doi: 10.1136/gutjnl-2019-319391.
    PubMed    
    
    
    
26. REN J, Yao M
    Cautious view on the link between yoghurt consumption and risk of colorectal cancer.
    Gut. 2019 Jul 29. pii: gutjnl-2019-319430. doi: 10.1136/gutjnl-2019-319430.
    PubMed    
    
    
    
27. DE VRIES NL, van Unen V, Ijsselsteijn ME, Abdelaal T, et al
    High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity.
    Gut. 2019 Jul 3. pii: gutjnl-2019-318672. doi: 10.1136/gutjnl-2019-318672.
    PubMed     Abstract available
    
    
    June 2019
28. ZHENG X, Wu K, Song M, Ogino S, et al
    Yogurt consumption and risk of conventional and serrated precursors of colorectal cancer.
    Gut. 2019 Jun 17. pii: gutjnl-2019-318374. doi: 10.1136/gutjnl-2019-318374.
    PubMed    
    
    
    
29. BAHIN FF, Heitman SJ, Bourke MJ
    Wide-field endoscopic mucosal resection versus endoscopic submucosal dissection for laterally spreading colorectal lesions: a cost-effectiveness analysis.
    Gut. 2019;68:1130.
    PubMed    
    
    
    May 2019
30. DOHAN A, Gallix B, Guiu B, Le Malicot K, et al
    Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab.
    Gut. 2019 May 17. pii: gutjnl-2018-316407. doi: 10.1136/gutjnl-2018-316407.
    PubMed     Abstract available
    
    
    
31. VUIK FE, Nieuwenburg SA, Bardou M, Lansdorp-Vogelaar I, et al
    Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years.
    Gut. 2019 May 16. pii: gutjnl-2018-317592. doi: 10.1136/gutjnl-2018-317592.
    PubMed     Abstract available
    
    
    April 2019
32. ZORZI M, Zappa M
    Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates.
    Gut. 2019 Apr 30. pii: gutjnl-2019-318589. doi: 10.1136/gutjnl-2019-318589.
    PubMed     Abstract available
    
    
    
33. VAUGHAN-SHAW PG, Zgaga L, Ooi LY, Theodoratou E, et al
    Low plasma vitamin D is associated with adverse colorectal cancer survival after surgical resection, independent of systemic inflammatory response.
    Gut. 2019 Apr 25. pii: gutjnl-2018-317922. doi: 10.1136/gutjnl-2018-317922.
    PubMed     Abstract available
    
    
    
34. LANNAGAN TRM, Lee YK, Wang T, Roper J, et al
    Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis.
    Gut. 2019;68:684-692.
    PubMed     Abstract available
    
    
    
35. TIE J, Cohen JD, Wang Y, Li L, et al
    Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study.
    Gut. 2019;68:663-671.
    PubMed     Abstract available
    
    
    February 2019
36. CHEUNG KS, Chen L, Chan EW, Seto WK, et al
    Statins reduce the progression of non-advanced adenomas to colorectal cancer: a postcolonoscopy study in 187 897 patients.
    Gut. 2019 Feb 26. pii: gutjnl-2018-317714. doi: 10.1136/gutjnl-2018-317714.
    PubMed     Abstract available
    
    
    
37. HE Z, Gharaibeh RZ, Newsome RC, Pope JL, et al
    Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin.
    Gut. 2019;68:289-300.
    PubMed     Abstract available
    
    
    
38. NGU WS, Bevan R, Tsiamoulos ZP, Bassett P, et al
    Improved adenoma detection with Endocuff Vision: the ADENOMA randomised controlled trial.
    Gut. 2019;68:280-288.
    PubMed     Abstract available
    
    
    January 2019
39. LOPEZ A, Bouvier AM, Jooste V, Cottet V, et al
    Outcomes following polypectomy for malignant colorectal polyps are similar to those following surgery in the general population.
    Gut. 2019;68:111-117.
    PubMed     Abstract available
    
    
    December 2018
40. STJARNGRIM J, Ekbom A, Hammar U, Hultcrantz R, et al
    Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?
    Gut. 2018 Dec 15. pii: gutjnl-2018-316651. doi: 10.1136/gutjnl-2018-316651.
    PubMed     Abstract available
    
    
    
41. SENORE C, Basu P, Anttila A, Ponti A, et al
    Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report.
    Gut. 2018 Dec 10. pii: gutjnl-2018-317293. doi: 10.1136/gutjnl-2018-317293.
    PubMed     Abstract available
    
    
    
42. LADABAUM U
    Occult blood in faeces: a window into health beyond the colorectum?
    Gut. 2018;67:2079-2080.
    PubMed    
    
    
    November 2018
43. COKER OO, Nakatsu G, Dai RZ, Wu WKK, et al
    Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer.
    Gut. 2018 Nov 24. pii: gutjnl-2018-317178. doi: 10.1136/gutjnl-2018-317178.
    PubMed     Abstract available
    
    
    
44. BAHIN FF, Heitman SJ, Rasouli KN, Mahajan H, et al
    Wide-field endoscopic mucosal resection versus endoscopic submucosal dissection for laterally spreading colorectal lesions: a cost-effectiveness analysis.
    Gut. 2018;67:1965-1973.
    PubMed     Abstract available
    
    
    
45. BUGAJSKI M, Wieszczy P, Hoff G, Rupinski M, et al
    Modifiable factors associated with patient-reported pain during and after screening colonoscopy.
    Gut. 2018;67:1958-1964.
    PubMed     Abstract available
    
    
    October 2018
46. CHEN H, Li N, Ren J, Feng X, et al
    Participation and yield of a population-based colorectal cancer screening programme in China.
    Gut. 2018 Oct 30. pii: gutjnl-2018-317124. doi: 10.1136/gutjnl-2018-317124.
    PubMed     Abstract available
    
    
    
47. DEKKER E, IJspeert JEG
    Serrated pathway: a paradigm shift in CRC prevention.
    Gut. 2018;67:1751-1752.
    PubMed    
    
    
    
48. GERNER RR, Klepsch V, Macheiner S, Arnhard K, et al
    NAD metabolism fuels human and mouse intestinal inflammation.
    Gut. 2018;67:1813-1823.
    PubMed     Abstract available
    
    
    September 2018
49. GUDRA D, Shoaie S, Fridmanis D, Klovins J, et al
    A widely used sampling device in colorectal cancer screening programmes allows for large-scale microbiome studies.
    Gut. 2018 Sep 21. pii: gutjnl-2018-316225. doi: 10.1136/gutjnl-2018-316225.
    PubMed    
    
    
    
50. TOES-ZOUTENDIJK E, Kooyker AI, Elferink MA, Spaander MCW, et al
    Stage distribution of screen-detected colorectal cancers in the Netherlands.
    Gut. 2018;67:1745-1746.
    PubMed    
    
    
    
51. TOYOSHIMA O, Hata K, Yoshida S, Arita M, et al
    New-generation chromoendoscopy may increase confidence in the DISCARD2 study.
    Gut. 2018;67:1742-1743.
    PubMed    
    
    
    
52. MURPHY G, Cross AJ, Dawsey SM, Stanczyk FZ, et al
    Serum ghrelin is associated with risk of colorectal adenocarcinomas in the ATBC study.
    Gut. 2018;67:1646-1651.
    PubMed     Abstract available
    
    
    August 2018
53. POHL H, Kaminski MF
    Mindful choice of endoscopic resection for large colorectal lesions.
    Gut. 2018;67:1374-1375.
    PubMed    
    
    
    
54. FUCCIO L, Repici A, Hassan C, Ponchon T, et al
    Why attempt en bloc resection of non-pedunculated colorectal adenomas? A systematic review of the prevalence of superficial submucosal invasive cancer after endoscopic submucosal dissection.
    Gut. 2018;67:1464-1474.
    PubMed     Abstract available
    
    
    July 2018
55. LIBBY G, Fraser CG, Carey FA, Brewster DH, et al
    Occult blood in faeces is associated with all-cause and non-colorectal cancer mortality.
    Gut. 2018 Jul 16. pii: gutjnl-2018-316483. doi: 10.1136/gutjnl-2018-316483.
    PubMed     Abstract available
    
    
    
56. BAKER AM, Cross W, Curtius K, Al Bakir I, et al
    Evolutionary history of human colitis-associated colorectal cancer.
    Gut. 2018 Jul 10. pii: gutjnl-2018-316191. doi: 10.1136/gutjnl-2018-316191.
    PubMed     Abstract available
    
    
    
57. CHANG WL, Jackson C, Riel S, Cooper HS, et al
    Differential preventive activity of sulindac and atorvastatin in Apc(+/Min-FCCC)mice with or without colorectal adenomas.
    Gut. 2018;67:1290-1298.
    PubMed     Abstract available
    
    
    June 2018
58. KOMIYA Y, Shimomura Y, Higurashi T, Sugi Y, et al
    Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity.
    Gut. 2018 Jun 22. pii: gutjnl-2018-316661. doi: 10.1136/gutjnl-2018-316661.
    PubMed    
    
    
    
59. WIETEN E, Schreuders EH, Grobbee EJ, Nieboer D, et al
    Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and meta-analysis.
    Gut. 2018 Jun 22. pii: gutjnl-2017-315340. doi: 10.1136/gutjnl-2017-315340.
    PubMed     Abstract available
    
    
    
60. NIEUWENBURG SAV, Vuik FER, Kruip MJHA, Kuipers EJ, et al
    Effect of anticoagulants and NSAIDs on accuracy of faecal immunochemical tests (FITs) in colorectal cancer screening: a systematic review and meta-analysis.
    Gut. 2018 Jun 5. pii: gutjnl-2018-316344. doi: 10.1136/gutjnl-2018-316344.
    PubMed     Abstract available
    
    
    May 2018
61. GLUCK N, Half EE, Bieber V, Schwartz D, et al
    Novel prep-less X-ray imaging capsule for colon cancer screening: a feasibility study.
    Gut. 2018 May 21. pii: gutjnl-2018-316127. doi: 10.1136/gutjnl-2018-316127.
    PubMed    
    
    
    
62. TEN HOVE JR, Shah SC, Shaffer SR, Bernstein CN, et al
    Consecutive negative findings on colonoscopy during surveillance predict a low risk of advanced neoplasia in patients with inflammatory bowel disease with long-standing colitis: results of a 15-year multicentre, multinational cohort study.
    Gut. 2018 May 2. pii: gutjnl-2017-315440. doi: 10.1136/gutjnl-2017-315440.
    PubMed     Abstract available
    
    
    
63. BARENDSE RM, Musters GD, de Graaf EJR, van den Broek FJC, et al
    Randomised controlled trial of transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND Study).
    Gut. 2018;67:837-846.
    PubMed     Abstract available
    
    
    April 2018
64. KONG F, Li L, Wang G, Deng X, et al
    VDR signaling inhibits cancer-associated-fibroblasts' release of exosomal miR-10a-5p and limits their supportive effects on pancreatic cancer cells.
    Gut. 2018 Apr 25. pii: gutjnl-2018-316627. doi: 10.1136/gutjnl-2018-316627.
    PubMed    
    
    
    
65. SMITH T, Muller DC, Moons KGM, Cross AJ, et al
    Comparison of prognostic models to predict the occurrence of colorectal cancer in asymptomatic individuals: a systematic literature review and external validation in the EPIC and UK Biobank prospective cohort studies.
    Gut. 2018 Apr 3. pii: gutjnl-2017-315730. doi: 10.1136/gutjnl-2017-315730.
    PubMed     Abstract available
    
    
    
66. CAO Y, Wu K, Mehta R, Drew DA, et al
    Long-term use of antibiotics and risk of colorectal adenoma.
    Gut. 2018;67:672-678.
    PubMed     Abstract available
    
    
    
67. MOUSSATA D, Allez M, Cazals-Hatem D, Treton X, et al
    Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
    Gut. 2018;67:616-624.
    PubMed     Abstract available
    
    
    
68. BATTERSBY NJ, Bouliotis G, Emmertsen KJ, Juul T, et al
    Development and external validation of a nomogram and online tool to predict bowel dysfunction following restorative rectal cancer resection: the POLARS score.
    Gut. 2018;67:688-696.
    PubMed     Abstract available
    
    
    March 2018
69. JOO JE, Jayasekara H, Wong EM, Clendenning M, et al
    Assessing the ProMCol classifier as a prognostic marker for non-metastatic colorectal cancer within the Melbourne Collaborative Cohort Study.
    Gut. 2018 Mar 24. pii: gutjnl-2018-316122. doi: 10.1136/gutjnl-2018-316122.
    PubMed    
    
    
    
70. RIGTER LS, Snaebjornsson P, Rosenberg EH, Atmodimedjo PN, et al
    Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
    Gut. 2018;67:447-455.
    PubMed     Abstract available
    
    
    
71. DAVENPORT JR, Su T, Zhao Z, Coleman HG, et al
    Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps.
    Gut. 2018;67:456-465.
    PubMed     Abstract available
    
    
    February 2018
72. SUNDKVIST A, Myte R, Palmqvist R, Harlid S, et al
    Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer.
    Gut. 2018 Feb 28. pii: gutjnl-2018-316110. doi: 10.1136/gutjnl-2018-316110.
    PubMed    
    
    
    
73. CREMONESI E, Governa V, Garzon JFG, Mele V, et al
    Gut microbiota modulate T cell trafficking into human colorectal cancer.
    Gut. 2018 Feb 6. pii: gutjnl-2016-313498. doi: 10.1136/gutjnl-2016-313498.
    PubMed     Abstract available
    
    
    
74. OVERWATER A, Kessels K, Elias SG, Backes Y, et al
    Endoscopic resection of high-risk T1 colorectal carcinoma prior to surgical resection has no adverse effect on long-term outcomes.
    Gut. 2018;67:284-290.
    PubMed     Abstract available
    
    
    
75. RICHARDS CH, Ventham NT, Mansouri D, Wilson M, et al
    An evidence-based treatment algorithm for colorectal polyp cancers: results from the Scottish Screen-detected Polyp Cancer Study (SSPoCS).
    Gut. 2018;67:299-306.
    PubMed     Abstract available
    
    
    January 2018
76. WILLIAMS DS, Mouradov D, Jorissen RN, Newman MR, et al
    Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
    Gut. 2018 Jan 30. pii: gutjnl-2017-315664. doi: 10.1136/gutjnl-2017-315664.
    PubMed     Abstract available
    
    
    
77. DE ARCANGELIS A, Chamaillard M, Simon-Assmann P, Labouesse M, et al
    Integrin a6 loss promotes colitis-associated colorectal cancer. Response to: "Integrin a6 variants and colorectal cancer" by Beaulieu JF.
    Gut. 2018 Jan 3. pii: gutjnl-2017-315727. doi: 10.1136/gutjnl-2017-315727.
    PubMed    
    
    
    
78. BACKES Y, Schwartz MP, Ter Borg F, Wolfhagen FHJ, et al
    Multicentre prospective evaluation of real-time optical diagnosis of T1 colorectal cancer in large non-pedunculated colorectal polyps using narrow band imaging (the OPTICAL study).
    Gut. 2018 Jan 3. pii: gutjnl-2017-314723. doi: 10.1136/gutjnl-2017-314723.
    PubMed     Abstract available
    
    
    
79. LAWLER M, Alsina D, Adams RA, Anderson AS, et al
    Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.
    Gut. 2018;67:179-193.
    PubMed     Abstract available
    
    
    
80. CARBALLAL S, Maisterra S, Lopez-Serrano A, Gimeno-Garcia AZ, et al
    Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD.
    Gut. 2018;67:70-78.
    PubMed     Abstract available
    
    
    December 2017
81. DEMING DA
    Tailoring the colorectal cancer disease assessment to the treatment strategy.
    Gut. 2017 Dec 21. pii: gutjnl-2017-315394. doi: 10.1136/gutjnl-2017-315394.
    PubMed    
    
    
    
82. SIEVERS CK, Zou LS, Pickhardt PJ, Matkowskyj KA, et al
    Subclonal diversity arises early even in small colorectal tumours and contributes to differential growth fates.
    Gut. 2017;66:2132-2140.
    PubMed     Abstract available
    
    
    November 2017
83. WAN L, Yu W, Shen E, Sun W, et al
    SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
    Gut. 2017 Nov 7. pii: gutjnl-2017-314983. doi: 10.1136/gutjnl-2017-314983.
    PubMed     Abstract available
    
    
    
84. GUNDERT M, Edelmann D, Benner A, Jansen L, et al
    Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier).
    Gut. 2017 Nov 3. pii: gutjnl-2017-314711. doi: 10.1136/gutjnl-2017-314711.
    PubMed     Abstract available
    
    
    
85. ZORZI M, Hassan C, Capodaglio G, Fedato C, et al
    Long-term performance of colorectal cancer screening programmes based on the faecal immunochemical test.
    Gut. 2017 Nov 3. pii: gutjnl-2017-314753. doi: 10.1136/gutjnl-2017-314753.
    PubMed     Abstract available
    
    
    October 2017
86. MAZARD T, Boonsirikamchai P, Overman MJ, Asran MA, et al
    Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab.
    Gut. 2017 Oct 30. pii: gutjnl-2017-313786. doi: 10.1136/gutjnl-2017-313786.
    PubMed     Abstract available
    
    
    
87. BEAULIEU JF
    Integrin alpha6 variants and colorectal cancer.
    Gut. 2017 Oct 28. pii: gutjnl-2017-315415. doi: 10.1136/gutjnl-2017-315415.
    PubMed    
    
    
    
88. SCHRAMM C, Janhsen K, Demir M, Nierhoff D, et al
    Serrated polyposis syndrome may go undiagnosed even in structured colorectal cancer screening programmes performed by endoscopists with otherwise good quality indices.
    Gut. 2017 Oct 21. pii: gutjnl-2017-315321. doi: 10.1136/gutjnl-2017-315321.
    PubMed    
    
    
    
89. FLEMER B, Warren RD, Barrett MP, Cisek K, et al
    The oral microbiota in colorectal cancer is distinctive and predictive.
    Gut. 2017 Oct 7. pii: gutjnl-2017-314814. doi: 10.1136/gutjnl-2017-314814.
    PubMed     Abstract available
    
    
    
90. BARAULT L, Amatu A, Siravegna G, Ponzetti A, et al
    Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.
    Gut. 2017 Oct 5. pii: gutjnl-2016-313372. doi: 10.1136/gutjnl-2016-313372.
    PubMed     Abstract available
    
    
    August 2017
91. ROBERTS SK
    Train-the-trainer education and colonoscopy quality indicators: where to now?
    Gut. 2017;66:1533-1534.
    PubMed    
    
    
    June 2017
92. BUCHANAN DD, Clendenning M, Zhuoer L, Stewart JR, et al
    Lack of evidence for germline RNF43 mutations in patients with serrated polyposis syndrome from a large multinational study.
    Gut. 2017;66:1170-1172.
    PubMed    
    
    
    March 2016
93. ADAMI HO, Bretthauer M, Emilsson L, Hernan MA, et al
    The continuing uncertainty about cancer risk in inflammatory bowel disease.
    Gut. 2016 Mar 23. pii: gutjnl-2015-311003. doi: 10.1136/gutjnl-2015-311003.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: